BMCS OTC
BioTech Medics, Inc.
1W: +0.0%
1M: +100.0%
3M: +100.0%
YTD: -97.5%
1Y: -97.7%
3Y: -98.7%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$3K
+37.7% ▲
Net Income
-$3K
+48.1% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$3K
-116.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $154K | $323K | $115K | $28K | $3K |
| Operating Expenses | $154K | $323K | $115K | $28K | $3K |
| Operating Income | -$154K | -$323K | -$115K | -$5K | -$3K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$110K | -$323K | -$115K | -$6K | -$3K |
| Tax Expense | $0 | $0 | $0 | -$168K | $0 |
| Net Income | -$110K | -$323K | -$115K | -$6K | -$3K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 |
| EBITDA | $97K | -$86K | -$115K | $186K | -$3K |
| Shares Outstanding | 202M | 202M | 202M | 202M | 202M |